Leading healthcare company Kimal plc has appointed a new Managing Director. Mark Pettitt joins the company as it looks to consolidate and build upon its success in core markets which include the UK and the Middle East.
In addition it is looking to break into new territories with its range of products used to diagnose and treat patients requiring cardiology, radiology, renal and oncology care.
“Beyond that, Kimal is committed to investing in new technologies to further develop its product portfolio and enhance its already enviable reputation,” says Mark.
“The company has conducted an in-depth review of its policies and procedures. One response to the findings has been the determination that the Leadership Team will have the responsibility for execution of objectives, from company targets to customer satisfaction, which are of course inter-dependent. I am pleased to have also been entrusted with the direct Chairmanship of this function.
“My joint roles share much in common, with an overall focus on delivering annual results within the existing product offering and markets. This is central to the success of Kimal and will underpin its wider ambitions.”
Looking specifically at the Leadership Team, it has representatives from all areas of the business, who share the common purpose of working together to develop customer-focused strategies in established markets and deliver performance targets through effective leadership.
Mark has instigated the development of a Leadership Team Charter to ensure that all involved are fully aware of their responsibilities. Members of the Team are accountable for their own specific business units and functions as well as taking responsibility for Kimal’s overall results.
Alan Press, Kimal plc’s chief executive, says: “Mark Pettitt has been appointed as managing director because of his experience and success to date as an established leader, gained with two multi-national healthcare companies. His expertise in building sales valued at millions of dollars and motivating large teams of people across numerous countries will be pivotal in taking the business forward. I wish him well in his role and also welcome him as a director on the board of Kimal Holdings plc.”
Mark will draw on his 24 years of experience managing sales and back office teams in the healthcare industry to identify the core processes necessary to achieving Kimal’s objectives.
“These range from budget and resource planning, fact-based decision making and strategic development to financial analysis and management of initiatives and processes,” he explains.
“Effective internal communication of progress and success will be central to encouraging everyone at Kimal to play their part. Their buy-in will continue to positively influence the culture at Kimal and translate into increasingly efficient operations, which will no doubt lead to a positive response from our customers. I anticipate and plan for a virtuous circle, of success breeding success.”
Kimal Medical Systems introduces the Kimal IVantage infusion pump
Leading medical devices company Kimal has introduced a solution for patients who need to take nutrition via IV lines but want to retain mobility. The...
Tuesday 1st June 2010